iZafe Group's CFO, Marius Sandberg, Purchases 177,793 Shares

November 14, 2024 7:45 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / November 14, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group's CFO, Marius Sandberg, has today acquired 177,793 B-shares in the company at a value of SEK 34,909 (SEK 0.196 per share).The acquisition was completed today, November 14, bringing Marius Sandberg's total shareholding in iZafe to 177,983 B-shares."As the new CFO, I see the potential that exists in iZafe, and with this share purchase, I am demonstrating my...

Read more

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

November 14, 2024 7:30 AM

CHATHAM, NJ / ACCESSWIRE / November 14, 2024 / For millions of people living with migraines, the pain can strike without warning, often during the most inconvenient times-like when they are fast asleep. The abrupt transition from sleep to a full-blown migraine leaves little room for preemptive action, especially when traditional oral migraine medications can take half an hour to an hour, or even more, to work. But for those seeking immediate...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Reports Third Quarter 2024 Results

November 14, 2024 7:00 AM

AUSTIN, TX / ACCESSWIRE / November 14, 2024 / Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced its financial results for the third quarter of 2024.The Company incurred a net loss of $7.1 million for the third quarter of 2024, or a loss of $1.53 per diluted share, as compared with a net loss of $10.4 million, or a loss of $29.35 per...

Read more

Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform

November 14, 2024 6:30 AM

Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the launch of its third equine-focused assay - Insulin for equine plasma - for the TRUFORMA In-Clinic Biosensor Testing Platform.Veterinarians test equine insulin levels when they suspect Equine Metabolic Syndrome (EMS) or other forms of insulin...

Read more

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024

November 13, 2024 5:33 PM

Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2024.Revenue for the quarter ended September 30, 2024 was $13.6 million compared to $12.9 million for the quarter ended September 30, 2023, an increase of $0.7 million or approximately 5.4%. The Company had operating income for the quarter ended September 30, 2024 of approximately $0.5 million compared to an...

Read more

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

November 13, 2024 4:15 PM

Dermata Therapeutics, Inc. (Nasdaq:DRMA; DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today highlighted recent corporate progress and reported financial results for the third quarter ended September 30, 2024."The third quarter was a busy time for our team as we approach completing enrollment in our DMT310 Phase 3 STAR-1 study and were able...

Read more

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

November 13, 2024 4:05 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced operational and financial results for the fiscal 2025 first quarter.​Q1 2025 Highlights ●ADHD Portfolio (Adzenys XR-ODT® and Cotempla XR-ODT®) net revenue increased 1% to $15.3 million versus $15.1 million in Q1 fiscal 2024. ●Pediatric Portfolio (Karbinal® ER, Poly-Vi-Flor® and Tri-Vi-Flor®) net...

Read more

Tenon Medical Reports Third Quarter 2024 Financial Results

November 13, 2024 4:05 PM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today reported financial results for the third quarter ended September 30, 2024.Third Quarter 2024 and Subsequent HighlightsRevenue of $0.9 Million in the third quarter of 2024, a 1.6% decrease over the second quarter of 2024. Revenue of $2.5 million year-to-date, an 18.3%...

Read more

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

November 13, 2024 4:05 PM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will participate in an Analyst-Moderated fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024 at 3:30 pm GMT. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.About...

Read more

Beta Bionics Announces Closing of a $60 Million Series E Financing

November 13, 2024 3:00 PM

IRVINE, CA / ACCESSWIRE / November 13, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announces the successful closing of a $60 million Series E Preferred Stock financing round.Beta Bionics iLet Bionic Pancreas The Series E funding was led by new investor Wellington Management. Previous investors Eventide Asset Management LLC, certain funds managed by RTW Investments, Sands Capital,...

Read more

Hopscotch Primary Care Welcomes New CEO, Tim Gronniger

November 13, 2024 1:00 PM

CHICAGO, IL / ACCESSWIRE / November 13, 2024 / Hopscotch Primary Care ("Hopscotch" or the "Company"), an innovator delivering technology-enabled primary care to rural communities, is proud to announce Tim Gronniger as their new CEO.Tim joins Hopscotch after serving as the Chief of Value-Based Care at Signify Health, a subsidiary of CVS Health. Prior to that, he was the CEO of Caravan Health, where he transformed the organization into the...

Read more

Gemina Laboratories Announces Private Placement

November 13, 2024 11:00 AM

VANCOUVER, BC / ACCESSWIRE / November 13, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7)(OCTQB:GLABF) (the "Company" or "Gemina") is pleased to announce a non-brokered private placement offering (the "Offering") of up to 9,333,333 common shares in the capital of the Company (each, a "Share") at a price of $0.75 per Share. The Offering is expected to raise gross proceeds of up to $7,000,000.The net proceeds of the Offering will be used to...

Read more

AcutePet Urgent Care Opens New Location in Bellevue, Kentucky

November 13, 2024 10:00 AM

Making Veterinary Care More Accessible and Affordable Through Urgent Care-Only ModelBELLEVUE, KY / ACCESSWIRE / November 13, 2024 / AcutePet Urgent Care is excited to announce the opening of its fourth location in Bellevue, Kentucky, on Wednesday, November 13, 2024. Conveniently located near the Daniel Carter Beard Bridge and I-71, I-75, and I-471, the new facility is also close to Newport on the Levee, Devou Park, and just a short drive from...

Read more

Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

November 13, 2024 9:20 AM

Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has received lead clinical site human research ethics committee ("HREC") approval that was required before dosing can begin in the Company's Phase 1b, 12-week chronic study GLP-1-H24-4, (the "Study").The Company is also announcing that clinical test article manufacturing for all planned Study arms has already...

Read more

KindlyMD(R) Announces Third Quarter 2024 Financial Results

November 13, 2024 9:00 AM

SALT LAKE CITY, UT / ACCESSWIRE / November 13, 2024 / ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company redefining value-based care and patient-centered medical services, today announced its financial results for the third quarter ended September 30, 2024."We are pleased with the progress made during the third quarter to expand our credentialing and increase insurance visits, resulting in a 16.4%...

Read more

The Menninger Clinic Offering Nation’s First Rapid Targeted Transcranial Magnetic Stimulation to Treat Depression

November 13, 2024 9:00 AM

Rapid Targeted Transcranial Magnetic Stimulation (TMS), a groundbreaking new treatment for depression, will now be available at The Menninger Clinic's Center for Brain Stimulation. The Houston-based mental health hospital is currently the only hospital in the U.S. to offer this treatment, which has shown to speed remission rates from depression.The Rapid Targeted TMS utilizes functional magnetic resonance imaging (fMRI) to identify the specific...

Read more

Circadia C200 System Gets FDA 510(k) Clearance, Transforming Senior Care With Contactless Heart Rate, Respiratory Rate, Motion, and Bed Exit Monitoring

November 13, 2024 9:00 AM

LOS ANGELES, CA / ACCESSWIRE / November 13, 2024 / Circadia Health, a trailblazer in innovative senior healthcare services, proudly announces FDA 510(k) clearance for the C200 System-a contactless respiratory rate, heart rate, motion, and bed exit monitoring device. Building on the success of the C100 System, a cutting-edge device for continuous respiratory monitoring, the C200 System is the world's first contactless device to be FDA-cleared for...

Read more

GAT Sport(R) Makes Triumphant Return to GNC, Launching All-New Nitraflex(R) ULTRA Pre-Workout

November 13, 2024 8:15 AM

GAT Sport® Reclaims GNC Shelves and Introduces Its Newest Nitraflex® ULTRA Pre-Workout in a Power Play That Strengthens Both Industry LeadersMONROE, CT / ACCESSWIRE / November 13, 2024 / GAT Sport®, a pioneer in sports nutrition, announces its highly anticipated partnership with GNC. This comeback is marked by the introduction of GAT Sport's new pre-workout Nitraflex® ULTRA to GNC's extensive network of stores.Nitraflex Ultra: Now Available...

Read more

Jaguar Health Reports Third Quarter 2024 Financial Results

November 13, 2024 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / November 13, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today reported its consolidated third-quarter 2024 financial results and provided Company updates.The total net revenue for the Company's Mytesi ® and Canalevia ® -CA1 prescription products, the Company's non-prescription products, and license revenue, was approximately $3.1 million in the third quarter of 2024, representing an...

Read more

The WiTT Group, Inc Completes a Financing Round Led by Sopris Capital With Participation From LEAD to Accelerate Growth and Build Out Its Patient Engagement and Data Platform

November 13, 2024 8:00 AM

SANTA CLARA, CA / ACCESSWIRE / November 13, 2024 / The WiTT Group™, Inc. a Digital Health and FinTech company focused on solving the non-clinical challenges patients face as they go through treatment, has announced the completion of a financing round led by Sopris Capital with participation from LEAD. WiTT Financing RoundSopris Capital, Lead.VC complete financing round with WiTT "We started WiTT to provide a platform where every patient can get...

Read more